Specializes entirely on AI-first businesses in technical domains (defense, robotics, drug discovery, AI infrastructure), utilizing the entrepreneur’s extensive AI analysis visibility and a press arm that fosters lab-to-lab debates.
Ranked by shared stages, industries, geography, cheque size and investor type. 400 related investors in the directory.
Formative-stage investor oriented toward AI-driven health, mobility, fintech/insurtech and intelligent enterprise, delivering hands-on GTM and roadmap support from ex-corporate venture leaders and engineers leveraging Allianz's risk, data, and regulatory expertise. With a disciplined investment approach, the team drives value for both founders and investors.
Builds AI companies from inception alongside recruited CEOs, acting as an AI R&D studio that sources ideas with large corporates to deliver agentic-AI ventures with built-in customers and traction. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
Deliberate 60/40 tech/healthcare split dedicated to de novo company formation, with a transparent debate-driven partner scoring system (1–4) and proven multi-generation continuity. With a clear focus on healthcare innovation, the firm brings both capital and domain expertise.
Crypto-native operators who architect token-first ecosystems via token design, governance, and collective bootstrapping, empowering founders construct enduring token economies from day one and backing 100+ on-chain projects.
Operator-led fund with deep cyber defense and software experience providing intensive, hands-on nurture capital and operational guidance geared toward sustainable market readiness and durability rather than unicorn chasing. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
Seed-stage investor in dual-use deep tech (six verticals) with an invite-only U.S. Service Academy alumni syndicate that co-invests, sources, vets deals, presents post-investment support, and runs a veteran-led track. The firm continues to build its presence across the venture capital landscape.
